Hormonsubstitution ved præmatur ovarieinsufficiens

Julie Isabelle Plougmann Gislinge; Cæcilie Weber Thomsen; Pernille Ravn

Hormonsubstitution ved præmatur ovarieinsufficiens

Julie Isabelle Plougmann Gislinge, Cæcilie Weber Thomsen, Pernille Ravn

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

6 Downloads (Pure)

Abstract

Premature ovarian insufficiency (POI) is defined as loss of ovarian function in women less-than 40 years. This review summarises the causes and the possible treatment options. POI can be idiopathic, caused by genetic, autoimmune, or metabolic disease, or be induced by cancer therapy or surgery. POI causes infertility, increased morbidity and mortality, and decreased quality of life. Hormonal replacement therapy (HRT) can alleviate symptoms of POI and should be initiated at diagnosis. The benefit of HRT outweighs the minor side effects in most cases and should be continued until age of natural menopause.

Bidragets oversatte titel	Hormone replacement in premature ovarian insufficiency
Originalsprog	Dansk
Artikelnummer	V01230012
Tidsskrift	Ugeskrift for Laeger
Vol/bind	186
Udgave nummer	1
Sider (fra-til)	51-54
ISSN	0041-5782
Status	Udgivet - 8. jan. 2024

Emneord

Female
Humans
Quality of Life
Primary Ovarian Insufficiency/diagnosis
Menopause, Premature
Infertility, Female/etiology
Hormones

Dokumenter og links

Open Access VersionForlagets udgivne version, 249 KBLicens: CC BY-NC-ND

https://ugeskriftet.dk/videnskab/hormonsubstitution-ved-praematur-ovarieinsufficiensLicens: CC BY-NC-ND

Citationsformater

@article{7f2c3abc5689463eb185fa03b411ef0f,

title = "Hormonsubstitution ved pr{\ae}matur ovarieinsufficiens",

abstract = "Premature ovarian insufficiency (POI) is defined as loss of ovarian function in women less-than 40 years. This review summarises the causes and the possible treatment options. POI can be idiopathic, caused by genetic, autoimmune, or metabolic disease, or be induced by cancer therapy or surgery. POI causes infertility, increased morbidity and mortality, and decreased quality of life. Hormonal replacement therapy (HRT) can alleviate symptoms of POI and should be initiated at diagnosis. The benefit of HRT outweighs the minor side effects in most cases and should be continued until age of natural menopause.",

keywords = "Female, Humans, Quality of Life, Primary Ovarian Insufficiency/diagnosis, Menopause, Premature, Infertility, Female/etiology, Hormones",

author = "Gislinge, {Julie Isabelle Plougmann} and Thomsen, {C{\ae}cilie Weber} and Pernille Ravn",

year = "2024",

month = jan,

day = "8",

language = "Dansk",

volume = "186",

pages = "51--54",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "1",

}

TY - JOUR

T1 - Hormonsubstitution ved præmatur ovarieinsufficiens

AU - Gislinge, Julie Isabelle Plougmann

AU - Thomsen, Cæcilie Weber

AU - Ravn, Pernille

PY - 2024/1/8

Y1 - 2024/1/8

N2 - Premature ovarian insufficiency (POI) is defined as loss of ovarian function in women less-than 40 years. This review summarises the causes and the possible treatment options. POI can be idiopathic, caused by genetic, autoimmune, or metabolic disease, or be induced by cancer therapy or surgery. POI causes infertility, increased morbidity and mortality, and decreased quality of life. Hormonal replacement therapy (HRT) can alleviate symptoms of POI and should be initiated at diagnosis. The benefit of HRT outweighs the minor side effects in most cases and should be continued until age of natural menopause.

AB - Premature ovarian insufficiency (POI) is defined as loss of ovarian function in women less-than 40 years. This review summarises the causes and the possible treatment options. POI can be idiopathic, caused by genetic, autoimmune, or metabolic disease, or be induced by cancer therapy or surgery. POI causes infertility, increased morbidity and mortality, and decreased quality of life. Hormonal replacement therapy (HRT) can alleviate symptoms of POI and should be initiated at diagnosis. The benefit of HRT outweighs the minor side effects in most cases and should be continued until age of natural menopause.

KW - Female

KW - Humans

KW - Quality of Life

KW - Primary Ovarian Insufficiency/diagnosis

KW - Menopause, Premature

KW - Infertility, Female/etiology

KW - Hormones

M3 - Tidsskriftartikel

C2 - 37539798

SN - 0041-5782

VL - 186

SP - 51

EP - 54

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 1

M1 - V01230012

ER -

Hormonsubstitution ved præmatur ovarieinsufficiens

Abstract

Emneord

Dokumenter og links

Fingeraftryk

Citationsformater